Arterial hepatic embolization of unresectable hepatocellular carcinoma using a cyanoacrylate/lipiodol mixture

CardioVascular and Interventional Radiology

Volumn 21, Issue 3, 1998, Pages 214-218

  Berghammer, Peter ^a   Pfeffel, Franz ^a   Winkelbauer, Fritz ^a   Wiltschke, Christoph ^a   Schenk, Thomas ^a   Lammer, Johannes ^a   Müller, Christian ^a   Zielinski, Christoph ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Embolization; Hepatocellular carcinoma; TAE; Transcatheter arterial

Indexed keywords

ALPHA FETOPROTEIN; ENBUCRILATE; IODINATED POPPYSEED OIL;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL;

AGED; CARCINOMA, HEPATOCELLULAR; CYANOACRYLATES; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; IODIZED OIL; LIVER NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 0031805193     PISSN: 01741551     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002709900247     Document Type: Article

References (22)

1. Saito I, Miyamura T, Ohbayashi A, Harada H, Katayama T, Kikuchi S, Watanabe Y, Koi S, Onji M, Ohta Y, et al. (1990) Hepatits C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci USA 87:6547-6549
2. Tsukuma H, Hiyama T, Tanaka S, Yabuuchi T, Kitamura T, Nakanishi K, Fujimoto I, Inoue A, Yamazaki H, et al. (1993) Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 328:1797-1801
3. Okuda K, Ohtsuki T, Obata H, Tomimatsu M, Okazaki N, Hasegawa H, Nakajima Y, Ohnishi K (1985) Natural history of carcinoma and prognosis in relation to treatment. Cancer 56:918-928
4. Bismuth H, Chiche L, Castaing D (1995) Surgical treatment of hepatocellular carcinomas in noncirrhotic liver: Experience with 68 liver resections. World J Surg 19-35-41
5. Li G, Li J, Zhang Y (1995) Results of hepatic resection for 600 cases with primary liver cancer. Chung-Hua-Chung-Liu-Tsa-Chih 17:125-128
6. Wu CC, Ho YZ, Ho, WL, Wu TC, Liu TJ, P'eng FK (1995) Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: A reappraisal Br J Surg 82:122-126
7. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire (1995) A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 332:1256-1261
8. Cromwell LD, Kerber CW (1979) Modification of cyanoacrylate for therapeutic embolization. Preliminary experience. AJR 132:799-801
9. Winkelbauer F, Niederle B, Pietschmann F, Thurnher S, Wildling R, Prokesch R, Lammer J (1995) Hepatic artery embolotherapy of hepatic metastases from carcinoid tumors: Value of using a mixture of cyanoacrylate and ethiodized oil. AJR 165:323-327
10. Bruix J, Castells A, Montanya X, Calvet X, Bru C, Ayuso C, Jover L, Garcia L, Vilana R, Boix L, et al. (1994) Phase II study of transarterial embolization in European patients with hepatocellular carcinoma: Need for controlled trials. Hepatology 20:643-650
11. Horiguchi Y, Itoh M, Takagawa H, Imai H, Kamei A, Sekoguchi B, Nagamura Y (1992) Assessment of chemoembolization therapy for primary liver cancer using a stabilized adriamycin-lipiodol suspension. Cancer Chemother Pharmacol 31:S60-S64
12. Kawai S, Tani M, Mikuriya S, Inoue J, Shimamura Y, Takahashi A, Masuzawa M, Jinno K, Makino M, Oda T (1990) Lipiodol transcatheter arterial chemoembolization for non-resectable hepatocellular carcinoma Multicenter cooperative study. Gan To Kagaku Ryoho 17:227-232
13. Kawai S, Tani M, Okamura J, Ogawa M, Ohashi Y, Monden M, Hayashi S, Inoue J, Kawarada Y, Kusano M, Kubo Y, Kuroda C, Sakata Y, Shimamura Y, Jinno K, Takahashi A, Takayasu K, Tamura K, Nagasue N, Nakanishi Y, Makino M, Masuzawa M, Yumoto Y, Takesada M, Oda T, The Cooperative Study Group for Liver Cancer Treatment of Japan (1994) Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma. A comparison between L-TAE with farmorubicin and L-TAE with adriamycin: Preliminary results (second cooperative study). Cooperative Study Group for Liver Cancer Treatment of Japan. Cancer Chemother Pharmacol 33:S97-S102
14. Nakao N, Kamino K, Miura K, Takayasu Y, Ohnishi M, Miura T (1992) Transcatheter arterial embolization in hepatocellular carcinoma: A long-term follow-up. Radiat Med 10:13-18
15. Tanaka K, Nakamura S, Numata K, Okazaki H, Endo O, Inoue S, Takamura Y, Sugiyama M, Ohaki Y (1992) Hepatocellular carcinoma: Treatment with percutaneous ethanol injection and transcatheter arterial embolization Radiology 185:457-460
16. Honguchi Y, Sekoguchi B, Imai H, Suzuki T, Kubo H, Itoh H, Itoh M (1994) Treatment of choice for unresectable small liver cancer: Percutaneous ethanol injection therapy or transarterial chemoembolization therapy. Cancer Chemother Pharmacol 33:S111-S114
17. Bronowicki JP, Vetter D, Dumas F, Boudjema K, Bader R, Weiss AM, Wenger JJ, Boissel P, Bigard MA, Doffoel M, et al. (1994) Transcatheter oily chemoembolization for hepatocellular carcinoma: A 4-year study of 127 French patients. Cancer 74:16-24
18. Stefanini GF, Amorati P, Biselli M, Mucci F, Celi A, Arienti V, Roversi R, Rossi C, Re G (1995) Efficacy of transarterial targeted treatments on survival of patients with hepatocellular carcinoma: An Italian experience. Cancer 75:2427-2434
19. Colleoni M, Gaion F, Liessi G, Mastropasqua G, Nelli P, Manente P (1994) Medical treatment of hepatocellular carcinoma Any progress? Tumori 80-315-326
20. Pelletier G, Roche A, Ink O, Anciaux ML, Derhy S, Rougier P, Lenoir C, Attali P, Etienne JP (1990) A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. J Hepatol 11:181-184
21. Sherman M (1995) Hepatocellular carcinoma. Gastroenterologist 3:55-66
22. Venook AP (1994) Treatment of hepatocellular carcinoma: Too many options? J Clin Oncol 12:1323-1334